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ABSTRACT 
 
An Evaluation of Asthma Surveillance Packaging and Dissemination Efforts in Georgia  
 
By 
 
Lauren Carin Potts 
 
April 10th 2017 
 
 
 
Asthma is a serious chronic disease that causes inflammation and narrowing of the airways. Due 
to the prevalence rates among children, asthma is a priority public health concern in the state of 
Georgia. The Georgia Asthma Control Program (GACP) seeks to improve asthma control by 
maximizing comprehensive asthma services. Surveillance is one of the ways this is done. This 
evaluation sought to determine the effectiveness and efficiency of asthma surveillance product 
packaging and dissemination efforts. The findings will be used to gain recommendations on how 
to improve surveillance products, reports, and the efforts that are made to disseminate the 
information. Four stakeholders were involved in the evaluation planning process to insure 
stakeholders’ needs would be met through the evaluation. Twelve stakeholders participated in 
evaluation interviews and focus groups in order to assess the effectiveness of current asthma 
surveillance products and dissemination. Interviews and focus group discussions were audio 
recorded to insure accuracy. A document review on current surveillance documents and the 
OASIS service were also performed. Stakeholders expressed their satisfaction with GACP 
surveillance products and dissemination efforts, and most also agreed that the data was easily 
accessible. Additionally, respondents indicated that there were few gaps in the data that is 
presently available, however others suggested additional measures and analysis that should be 
reported. Future recommendations include, making more efforts to get data and surveillance 
products to parents and community leaders, producing multiple surveillance documents for 
different audiences, updating surveillance data in a reasonable timeframe, and training all school 
staff to handle asthma events in children. 
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Introduction and Program Description  
 
 Asthma is a serious chronic disease that causes inflammation and narrowing of the airways that 
can result in wheezing, chest tightness or shortness of breath. Asthma is a high priority public health 
concern in the state of Georgia due to the prevalence rates of asthma among children aged 0-17.  Asthma 
“affects an estimated 5% to 10% of the population in the United States” and is responsible for costing the 
healthcare system billions of dollars every year (Wood et al. 2010). The prevalence of childhood asthma 
in the U.S. is increasing and is affecting African-Americans and children of lower socioeconomic status 
more so than others, like most chronic diseases (Harrington et al. 2015). Thus, African-American children 
are more likely to have asthma and have a significantly higher emergency department visit rate than 
Caucasian children (Wood et al. 2010). Additionally, African-American children are more than four times 
more likely to die from asthma-related complications than Caucasian children (Wood et al. 2010). These 
disparities are important to understand because similar to these nationwide trends, the asthma prevalence 
in Georgia is higher among African-American children. For example, the highest rates of asthma occur in 
non-Hispanic black children aged 0-17 (15.6%). Although this evaluation is not specific to African-
American children, large portions of the children that are patient participants in the Georgia Asthma 
Control Program are African-American and one of the expected outcomes of the surveillance activity is to 
reduce disparities.  
 The Georgia Asthma Control program is funded under the Funding Opportunity Announcement 
EH-RFA014-1404, through a cooperative agreement as part of CDC’s National Asthma Control Program. 
Under this agreement, the GACP was tasked with maximizing comprehensive asthma control services. 
The mission of the Georgia Asthma Control Program is to improve asthma control and reduce the burden 
in Georgia. This cooperative agreement seeks to do this by focusing on a variety of different aspects of 
asthma control including education and an integrated healthcare delivery system. Some expected 
outcomes include reducing disparities, expanding use of practice-based approaches to asthma control and 
an increase in asthma education. Of the many strategies that are used to achieve these goals, this 
evaluation will focus on infrastructure strategies, which include surveillance and evaluation.  
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CDC’s Evaluation Framework & Learning and Growing Evaluation tool kit was used for the planning and 
implementation of this evaluation. This framework provided a guide to determining the appropriate steps 
and choices to take while developing our approach and execution of the evaluation. An important part of 
this agreement is the development and implementation of the Strategic Evaluation Plan (SEP) and 
Individual Evaluation Plan (IEP). This SEP outlines the program evaluation activities and is intended to 
provide an overview of all planned evaluations for the cooperative agreement (See Figure 1.1 and Figure 
1.2). The developed IEPs provide a more detailed plan for each evaluation outlined in the SEP.   
   
 
 
 
Figure 1.1: Developing the Strategic Evaluation Plan  
Source: State Asthma Program Evaluation Guide:  Learning and Growing Through Evaluation, 2015 
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Figure 1.2: Developing the Individual Evaluation Plan  
Source: State Asthma Program Evaluation Guide:  Learning and Growing Through Evaluation, 2015 
 
 Surveillance is defined as “the ongoing systematic collection, analysis, interpretation and 
dissemination of health data for the planning, implementation and evaluation of public health action” 
(Choi et al., 2012). Surveillance is one of the essential functions of public health and can be used to detect 
early warning signs of health problems, impact assessment, intervention development/implementation, 
intervention evaluation, risk assessment and research (Choi et al., 2012). The Georgia Department of 
Public Health also uses Asthma surveillance data to compile information that is then made available to the 
public. For example, data summaries that include the current asthma prevalence, asthma 
hospitalizations/ER visits, information on how to tell if a child has asthma, and the different types of 
medications available.  
 Evaluations of surveillance programs are important because it helps ensure that public health 
problems are being monitored effectively (CDC). The focus of these evaluations should be how well the 
surveillance system achieves its goals and include recommendations on how to improve the quality and 
usefulness of the surveillance system (CDC). There are many frameworks for evaluation, including those 
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recommended by the CDC and NIH, however researchers can also create their own evaluation plan that is 
specific to the objectives of the surveillance program being evaluated.  
 
 
Evaluation Purpose 
 
 The purpose of this evaluation is to determine the effectiveness and efficiency of asthma 
surveillance product packaging and dissemination efforts in Georgia. Specifically, the goal was to answer 
the following evaluation questions from the perspective of stakeholders in the GACP : To what extent is 
asthma data accessible to stakeholders in the most appropriate format to inform program panning, 
implementation, and evaluation? Who is accessing asthma surveillance data? Are there gaps in the data 
that is presently available? What technical assistance is available on data access and interpretation? To 
what extent do the twelve evaluation participants rate asthma surveillance products as accessible, user-
friendly, and useful? To what extent is asthma surveillance data used to inform policy and program 
planning efforts across the state? Stakeholders include individuals that represent a variety of organizations 
including, the National Association of School Nurses, Children’s Healthcare of Atlanta, Mercer 
University, Georgia Asthma Coalition and the Asthma Task Force.  
 The findings of this evaluation will be used to offer recommendations on how to improve asthma 
surveillance products and reports, as well as the efforts that are made to disseminate the information 
obtained to stakeholders. This evaluation falls under the infrastructure strategies outlined in the strategic 
evaluation plan, and surveillance is prioritized as the number one program activity.  
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Evaluation Planning 
 
 
 
Planning Team  
 
 Asthma is a serious chronic disease that has a heavy burden in the state of Georgia. By evaluating 
the sources of asthma surveillance data (Behavioral Risk Factor Surveillance System, Youth Risk 
Behavior Surveillance System, the Asthma Callback Survey) and documents (Info graphics, Fact Sheets, 
Data Summaries, etc.), recommendations can be made that can be used to increase the effectiveness of 
asthma programs, interventions and data. This evaluation was designed to meet the need to continue to 
improve the way asthma surveillance data is formatted, distributed and used. The surveillance data 
analyzed was collected and used by a variety of public health partners. For example, school nurses, 
chronic disease prevention managers and the Georgia Asthma Advisory Board Members. An important 
part of the evaluation was developing an individual evaluation planning team. 
 The individuals involved in the planning of this evaluation included stakeholders who were 
interested and/or affected by the evaluation. These four stakeholders as listed in Table 2.1, are considered 
a part of the individual evaluation planning team and included GACP team members, healthcare 
professionals, community organizations and academic institutions. By including stakeholders in the 
evaluation planning process, we can assure that their needs and interests are represented over the course 
of the evaluation. The table below lists the stakeholders who were involved in the evaluation planning 
process. Primary stakeholders included those that were directly involved in completing evaluation, and 
secondary stakeholders were people who provided input into how the evaluation should be conducted. 
Individuals who are listed as reviewers were stakeholders that were interested in participating in the 
planning of the evaluation, and stated that they wanted to review the proposed plan and make 
recommendations. Individuals that are listed as participants were also a part of the group of stakeholders 
that participated in the interview and focus group portion of the evaluation.  
 The individuals who participated in the interviews and focus group consisted of stakeholders who 
were willing to provide comments and recommendations on the current asthma surveillance data and 
products. This second group of stakeholders represented asthma surveillance data users, school nurses, 
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direct service providers and national/federal partners. These stakeholders are the best source of data for 
this evaluation because they work in positions that utilize the data and data products and are able to 
comment on the asthma surveillance data, data products and dissemination efforts. For example, 
individuals that use the data and national/federal partners are able to address issues and technical 
difficulties when accessing the datasets, as well as inform on any policies or programs that have been 
implemented as a result of the surveillance data.  School nurses can provide feedback on how to make the 
surveillance documents more accessible and understandable to children and parents, and direct service 
providers are able to comment on how the surveillance materials are being used in other healthcare 
settings.  
 
 
Table 2.1. Planning Team  
Name Category 
Interest or 
Perspective 
Role in the Evaluation 
{May be an individual or a group} {primary, 
secondary, 
tertiary} 
{program 
participant, staff, 
etc.} 
{planning team, external 
reviewer, etc.} 
Debbie Okirie 
 
Secondary Reviewer Planning team  
Danella Abdul-bar Secondary Reviewer Planning team  
Lynn Meadows Secondary  Participant/ 
Reviewer  
Planning team 
Bentley Ponder Secondary Reviewer Planning team  
Lauren Potts  Primary  Evaluation  Evaluation facilitator  
Stephanie Hall  Primary  Evaluation  Lead Evaluator  
 
 
 
 
Logic Model 
 
 GACP’s inputs include the established state asthma program, GACP matrix team, state agency 
partners and the Georgia Asthma Advisory Coalition.  The goal is that these inputs is to help for example, 
determine surveillance indicators, identify data gaps and potential new sources of data and publish 
surveillance and evaluation products. This will lead to an updated surveillance plan, surveillance 
products, new data sets, fulfilled data requests, and an increased knowledge and understanding of the 
burden of asthma in Georgia. Ultimately, it is expected that the resources available, activities, and outputs 
will work to achieve the desired outcomes as outlined in the logic model in Figure 2.1.
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Figure 2.1: Surveillance Logic Model 
 
 
GEORGIA ASTHMA CONTROL PROGRAM: SURVEILLANCE EVALUATION LOGIC MODEL  
INPUTS STRATEGIES & ACTIVITIES OUTCOMES SELECT OUTPUTS 
Increased production 
of surveillance 
products for the 
public on asthma 
To collect information 
on prevalence, 
hospitalization, 
mortality, and risk for 
asthma in Georgia 
Increased knowledge 
& understanding of 
burden of asthma in 
Georgia  
Increased efforts by 
payers & health care 
organizations to 
improve the quality of 
asthma care 
Decreased gaps in 
surveillance data 
INFRASTRUCTURE STRATEGIES 
  
Surveillance Products (e.g. 
Briefs, Fact Sheets, 
Infographics) 
Updated Surveillance Plan  
New data sets identified  
Data requests fulfilled  
SHORT-TERM       
     
Increased use of asthma 
surveillance data by partners for 
planning, implementation and 
evaluation of interventions 
Increased the utilization of statewide 
surveillance system to access 
asthma data 
  
Data used to support policy 
development  
Increased funding to conduct 
asthma related projects 
To provide information to develop 
asthma management programs and 
evaluate the effectiveness of the 
program.  
INTERMEDIATE  
Increased quality of life for individuals w/ asthma  
Decreased burden of asthma  
-ED Visits  
-Hospitalizations 
-Asthma deaths  
School & work days missed   
-Health care & economic cost   
Decreased disparities in asthma burden  
Comprehensive asthma control services are expanded & 
sustained statewide 
Evidence based policies implemented to support improved 
asthma management or system changes resulting from use of 
surveillance data  
LONG-TERM 
Established state 
asthma program, 
surveillance system, 
evaluation and strategic 
communication strategy    
GACP Matrix Team 
(Program Manager, 
Program Coordinator, 
Epidemiologist, 
Evaluator) 
Funding, guidance, & 
support from CDC  
State Agency Partners  
- Communications 
- Environmental Health  
- Maternal and Child 
Health  
- Public Health Districts  
Strategic Partners  
- Georgia Asthma 
Coalition 
- Not One More Life 
- Choice Healthcare 
Network 
Georgia Asthma 
Advisory Coalition 
(GAAC) 
Surveillance data  
Strategic Plan for 
Addressing Asthma 
Care in Georgia 2013-
18 
Asthma Evidence base 
and promising practices 
  
Determine Surveillance Indicators 
Identify data gaps and potential 
new sources of data 
Publish and disseminate 
surveillance and evaluation 
products 
Conduct a webinar training and 
develop a reference guide 
describing how to use the Online 
Analytical Statistical information 
System (OASIS) and the types of 
data available from the system 
Provide surveillance data to 
stakeholders and partners in 
order to assist in guiding 
statewide intervention strategies 
  
Respond to data request from 
internal and external stakeholders 
Develop and implement a web 
query to examine access to an 
utilization of surveillance 
resources available on GACP 
website.  
Create maps and charts to 
demonstrate the alignment of 
program activities and asthma 
burden  
  
April 2017 
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Evaluation Design 
 
 
 Qualitative tools were selected based on the goals of the evaluation, the evaluation 
questions, and available resources. Focus groups and interviews were used to gain specific 
recommendations needed to make improvements. Through this method, we were able to have 
active participation and discussion of our stakeholders and include their thoughts and ideas 
expressed without limiting response options.  
 
Evaluation Questions 
 
Evaluation efforts answered the following questions as outlined in the Strategic Evaluation Plan:  
1) To what extent is asthma data accessible to stakeholders in the most 
appropriate format to inform program panning, implementation, and 
evaluation?  
a) Who is accessing asthma surveillance data?  
b) Are there gaps in the data that is presently available?  
c) What technical assistance on data access and interpretation?  
2) To what extent do users rate asthma surveillance products as accessible, user-
friendly, and useful?  
3) To what extent is asthma surveillance data used to inform policy and program 
planning efforts across the state? 
 
 
 
Data Collection Methods 
 
 Semi- structured interviews and focus groups were conducted to assess the effectiveness 
of current asthma surveillance product packaging and dissemination.  Participants were 
stakeholders in the Georgia Asthma Control Program and were recruited via email. A total of 
twelve participants were included in the interview and focus group part of the evaluation. The 
interview and focus group questions were guided by the overarching evaluation questions 
outlined in the Strategic Evaluation Plan. Questions assessed who accesses the available data, 
how the data is used and any issues associated with using or accessing the data. Interviews and 
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focus group discussions were audio recorded to ensure accuracy in the analysis. A document 
review was conducted by the researcher, and included asthma surveillance data published within 
the last seven years. (For a full list of the specific documents that were analyzed see Appendix C.) 
Table 2.2 outlines the overarching evaluation questions, the data collection methods used and the 
sources of the data collection.   
 
 
 
 
 
Table 2.2: Evaluation Questions and Associated Data Collection Methods 
Evaluation Question Data Collection Method Source of Data 
1. To what extent is asthma data accessible to 
stakeholders in the most appropriate format to 
inform program planning, implementation, and 
evaluation?  
Interview GAAC members, Website 
visitors, other partners 
Focus Group GAAC members, Website 
visitors, other partners 
Document Review  Burden Report, Data 
Summaries, other state 
surveillance documents,  
Surveillance data sources (e.g. 
BRFSS, Asthma Callback 
Survey) 
2. Who is accessing asthma surveillance data?  Interview  GAAC members, Website 
visitors, other partners 
Document Review  Burden Report, Data 
Summaries, other state 
surveillance documents,  
Surveillance data sources (e.g. 
BRFSS, Asthma Callback 
Survey) 
3. Are there gaps in the data that is presently 
available?  
Focus Group GAAC members, Website 
visitors, other partners 
Document Review  Burden Report, Data 
Summaries, other state 
surveillance documents,  
Surveillance data sources (e.g. 
BRFSS, Asthma Callback 
Survey) 
4. What technical assistance on data access and 
interpretation?  
Interview  GAAC members, Website 
visitors, other partners 
Document Review  Burden Report, Data 
Summaries, other state 
surveillance documents,  
Surveillance data sources (e.g. 
BRFSS, Asthma Callback 
Survey) 
5. To what extent do users rate asthma 
surveillance products as accessible, user 
Interview  GAAC members, Website 
visitors, other partners 
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friendly, and useful?  Focus Group GAAC members, Website 
visitors, other partners 
Document Review  Burden Report, Data 
Summaries, other state 
surveillance documents,  
Surveillance data sources (e.g. 
BRFSS, Asthma Callback 
Survey) 
6. To what extent is asthma surveillance data 
used to inform policy and program planning 
efforts across the state?  
Interview  GAAC members, Website 
visitors, other partners 
Focus Group  GAAC members, Website 
visitors, other partners 
 
 
 
Table 2.3 outlines the indicators and standards for success used for the evaluation. The indicators 
and standards were determined by the intern and lead evaluator and were based on previous 
evaluations.  These indicators and standards were also reviewed and approved by the individual 
evaluation planning team prior to beginning the evaluation.  
 
Table 2.3. Indicators and Success 
Evaluation Question Criteria or Indicator 
Standards 
(What Constitutes 
“Success”?) 
1. To what extent is asthma data accessible to 
stakeholders in the most appropriate format 
to inform program planning, implementation, 
and evaluation? 
# of stakeholders that report 
satisfaction with accessibility 
of surveillance data  
60% of stakeholders reporting 
satisfaction with accessibility 
2. Who is accessing asthma surveillance 
data? 
Number and type of 
individuals, groups, or 
organizations 
identified/represented that use 
asthma surveillance data 
At least 2 identified parties 
3. Are there gaps in the data that is presently 
available? 
Number and type of additional 
types of information that 
should be reported  
At least 2 new types of 
information identified  
4. What technical assistance on data access 
and interpretation? 
Number and type of  specific 
technical skills/software 
necessary to access the 
surveillance information 
identified 
At least 3 specific technical skills 
and/or software necessary to 
access the information  
5. To what extent do users rate asthma 
surveillance products as accessible, user 
friendly, and useful? 
# Of stakeholders that use 
asthma surveillance products in 
their daily lives 
60% of stakeholders reporting that 
they use asthma surveillance 
products in their daily lives 
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# Of surveillance documents 
that are below the 12th grade 
reading level  
60% of surveillance documents 
require a reading level below the 
12th grade 
6. To what extent is asthma surveillance data 
used to inform policy and program planning 
efforts across the state? 
# Of policies and/or programs 
that were implemented as a 
result of asthma surveillance 
products 
At least 3 policies and/or programs 
implemented as a result of asthma 
surveillance products 
 
 
Analysis 
 
 Descriptive analysis of interview responses were used to determine how the data is 
accessed, any issues associated with accessing the data, how the data is used and how the data is 
distributed. The questions were worded so that the responses could be categorized and counted 
for example, if they agreed or disagreed with a particular statement. A document review of the 
currently available asthma surveillance data products was done to assess the readability, context, 
design, layout, type of document, and any additional information that should be presented.  
 
 
Interpretation 
  
 The results of this evaluation will be used to develop improvements that can be made to 
currently available asthma surveillance data products, and support the need to increase and 
improve the amount of information available that defines the burden of asthma in Georgia. These 
improvements in the asthma surveillance data may also be used to support GACP initiatives, as 
well as other asthma management programs and policies. Evaluation findings will also be used to 
make recommendations on how to improve asthma surveillance product packaging and 
dissemination efforts by GACP. Additionally, these findings will be used to support data sharing 
agreements with other organizations that may help create new and better methods of data 
collection. These findings will be communicated to the evaluation team through final evaluation 
reports, evaluation summaries and final presentations. Finally, these results will also be made 
   
22 
available on the DPH website and shared with all stakeholders via email blasts, the GAAB 
meeting and updated with CDC.  
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Section 3: Surveillance Evaluation Report  
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Introduction  
 
 This evaluation was conducted to gain recommendations on how to improve asthma 
surveillance data collection and dissemination efforts in the state of Georgia. Surveillance is 
prioritized as the number one program activity as outlined in the Strategic Evaluation Plan (SEP) 
and is particularly important due to the high prevalence rates of asthma in children in Georgia. 
The evaluation questions were designed to obtain input on the accessibility, usability, gaps, and 
any technical issues associated with accessing the data. This section provides the methods that 
were used to complete the evaluation, as well recommendations based off of the results found and 
limitations of the evaluation.  
 
Methods 
 
 Interviews and focus groups were conducted to assess the effectiveness of current asthma 
surveillance product packaging and dissemination. Participants were stakeholders in the Georgia 
Asthma Control Program and were recruited via email. A total of twelve participants were 
included in the evaluation. Questions of interest were outlined in the Strategic Evaluation Plan 
and were listed previously in the Purpose section. A list of the specific questions asked during the 
interviews and focus group can be found in Appendix A and B. Interviews and focus group 
discussions were audio recorded to insure accuracy in the analysis. Georgia State University 
Institutional Review Board approved all recruitment materials, interview questions, and data 
collection methods. A document review was also performed to analyze the surveillance resources 
that are currently available and that were developed within the last seven years. While reviewing 
the documents the readability, context, design, layout and type of document was assessed. There 
were a variety of surveillance resources that were examined in this evaluation. In addition to the 
surveillance documents, the accessibility and usability of the asthma data on the OASIS service 
was analyzed.  
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Results  
 
 Below are the results of the GACP Surveillance Evaluation. Stakeholders that 
participated represented program data users, school nurses, direct service providers and 
national/federal partners as shown in Figure 3.1.  
Figure 3.1: Participant Representation  
 
 
 
Interviews/Focus Group   
 
 Overall, all respondents indicated that they used the asthma surveillance data and were 
satisfied with the accessibility. Although most respondents agreed that these surveillance products 
are easy to understand, most stakeholders also agreed that there would be a strong benefit to 
having multiple versions of the same surveillance information. For example, a version for 
healthcare providers and those with a science background, and another version for parents, 
children and the general public. Their reasons included that those that do not have a science 
background may not be able to understand the information that is being presented as effectively, 
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and that this could be a potential reason why people are not implementing interventions and 
policy’s as aggressively as needed.  
 There were also multiple organizations and groups identified by the participants that use 
the asthma surveillance data, including Georgia Asthma Management Education in the Childcare 
Setting, The Asthma Friendly Schools Program, Children’s Healthcare of Atlanta, National 
Association of School Nurses, Georgia Asthma Coalition, and the Asthma Task Force. 
Stakeholders also expressed additional types of information that should be reported such as more 
data on children that have parents that smoke, daily rates of ER visits and the number of kids in 
each school district that have asthma. Most also expressed that they use the surveillance products 
in their daily lives, and that no specific technical skill or software is necessary to access the 
surveillance information. However, some stakeholders admitted to initially having issues learning 
how to use the OASIS service, for example learning how to filter results. Finally, the New Ronald 
McDonald Children’s Healthcare of Atlanta Care Mobile and Not One More Life were identified 
as programs that were implemented because of the asthma surveillance data. The New Ronald 
McDonald Children’s Healthcare of Atlanta Care Mobile provides medical care for children with 
asthma, asthma education and screenings and Not One More Life is an asthma education program 
dedicated to teaching others about asthma.  
 
Document Review 
 For the document review, twelve documents and two info graphics were analyzed.  Of the 
documents that had a readability that could be determined (7/14), they all had readability below 
the 12th grade. The 12th grade reading level was chosen as the indicator because most patient 
educational materials are made to be understood by someone who has at least a 12th grade reading 
level (Neilsen-Bohlman et al., 2004).  The diagrams within these asthma surveillance products 
were overall easy to understand, however some documents contained graphs that were difficult to 
follow. Additionally, some documents contained tables that had statistical information that would 
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not be easily understood by someone who does not have a science background or are not trained 
in statistical methods. Many stakeholders, as explained previously, also expressed this 
observation. While this information is appreciated and necessary for people who work in the 
healthcare field, these tables provide little understandable information to the average person. The 
formats of some of the Fact Sheets also made these documents difficult to read because the pages 
were really wordy and crowded, making them hard to interpret.  
 The OASIS service was found to be a very good tool to use to gain valuable information 
on asthma data. The website is very straightforward, clear and easy to navigate. There is a large 
amount of information available, thus it became clear why some stakeholders reported some 
difficulty getting a grasp of all that was there on the website. Additionally, there was not a lot of 
recent data available.  
  
Conclusions and Recommendations 
 
 Overall, stakeholders expressed that they were satisfied with GACP surveillance products 
and dissemination efforts. With respect to accessing the data, most respondents agreed that the 
data was easily accessible and the most common method was through the DPH website or the 
OASIS service. Respondents also indicated that there were gaps in the data that was presently 
available and suggested additional measures and analysis that should be reported and conducted. 
A complete list of additional measures and analysis that stakeholders suggested can be found in 
Table 4 in the appendix. Through the content analysis similar recommendations were made, 
including generating multiple surveillance documents for different audiences. The need to make 
some documents more than one page to make room for more space between paragraphs and allow 
graphs and charts to be more legible was also mirrored through the content analysis. Stakeholders 
may also benefit from OASIS training workshops in order to learn how to filter results faster and 
gain a good understanding of everything this service has to offer.  
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 In conclusion the recommendations that were suggested by multiple participants include: 
Make more efforts to get data and surveillance products into the hands of parents and community 
leaders, produce multiple surveillance documents for different audiences, update surveillance data 
quicker, and train all school staff to handle asthma events in children. Based on these evaluation 
findings the GACP Matrix Team developed activities to implement these changes are outlined in 
the Action Plan. The activities designed to make more efforts to get data and surveillance 
products into the hands of parents and community leaders include sharing data products with 
partners via emails and meetings, and requesting that they share these data products with their 
respective networks. Additionally, exploring social media options, which includes working with 
communication to help spread the word of new documents via Facebook, Twitter and other social 
media outlets.  
 The activities designed to produce multiple surveillance documents for different 
audiences include the development of factsheets, data summaries and infographics specific to 
childcare centers, parents/families, healthcare providers, CMOs/HCOs and youth. The topics 
these surveillance products should cover include information on general asthma, asthma devices 
and medications, albuterol stocking, school asthma policies, and asthma action plans. Childcare 
centers include places that take care of children from ages 0-4, parents and families include 
people that are parents or part of a family of children with asthma, and healthcare providers are 
people or organizations that provide healthcare to people.  For example doctors, physician 
assistants and nurses. CMOs/HCOs are organizations that provide effective programs and 
services to patients in addition to providing insurance coverage and reimbursements for 
healthcare costs. Examples include, Amerigroup, Medicaid and WellStar. Youth include children 
under the age of 18. The topic of general asthma should cover definitions of asthma and asthma 
triggers. Documents on asthma devices should include information on how to use inhalers, 
nebulizers and spacers. Albuterol stocking documents should address and provide information on 
the School Based Asthma Management Program Act, which allows schools to stock albuterol and 
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epinephrine for students who present with asthma symptoms and do not have their a personal 
inhaler on them. School asthma policy documents should cover any new legislation that effects 
asthma management in schools. Finally, surveillance products that address asthma action plans 
should go over steps that should be taken to plan for asthma episodes.  
 The activities designed to update the surveillance data on a clear and consistent timeline 
include trainings and webinars, alternate data collection, collaboration with the Chronic Disease 
Epidemiology section at GDPH, and collaboration with the Office of Health Indicators for 
Planning (OHIP). Alternate data collection should include collecting data via school districts, 
public health districts and other health partners. Collaboration with the Chronic Disease 
Epidemiology section should help to maintain constant communication, insuring that it will be 
known when the analysis will be done and when the information will be made available. Finally, 
collaborating with OHIP should make it easier to communicate when the data will be updated on 
the OASIS service.  
 The activities to train all school staff to handle asthma related events in children include 
meetings with school staff and school nurses, and providing webinar trainings to all school staff. 
Meetings with school staff and school nurses should provide them with information and resources 
on effective asthma management that can then be dispersed so that staff can be prepared to handle 
children with asthma. Finally, webinars and trainings should inform school staff on how to 
respond to a child that has an asthma episode.  
 
 
Limitations 
 
 One limitation of this evaluation is that parents of children with asthma were not included 
in the assessment, and specifically evaluated the asthma surveillance from the perspective of 
individuals and organizations that work to support the goals of the GACP. Future evaluations 
could gain valuable insight into how the surveillance data products are used by people who care 
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for their children at home as well as recommendations on how to improve access and usability of 
the data products specific to their needs. Another limitation is that the readability of all of the 
documents included in the document review was not able to be determined. This makes it difficult 
to draw conclusions and determine if the standard had been met. Finally, there is variability in the 
literature around the assessment of health literacy through the readability of a particular 
document. Some studies suggest that a reading level below the 9th grade indicates low health 
literacy and others suggest a reading level as low as 5th grade (DeWalt et al., 2007) (Badarudeen 
& Sabharwal, 2010). The decision to use the 12th grade reading level was also supported by 
literature given the age of our participants, however future evaluations might consider looking at 
health literacy using a lower reading level as a standard. Additionally, future evaluations might be 
able to assess the reading level of a sample of individuals who use the asthma surveillance 
products, for example parents of children with asthma, then use the average reading level as a 
standard for the document review. 
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Action Plan  
(Based on evaluation findings) 
 
Program Component: Surveillance  
Evaluation Purpose: to determine the effectiveness and efficiency of asthma surveillance product packaging and dissemination efforts in Georgia 
Programmatic Change Sought:  
Evaluation Result:  1) Make more efforts to get data and surveillance products into the hands of parents and community leaders 
2) Produce multiple surveillance documents for different audiences 
3) Update surveillance data in a more timely manner 
4) Assist in training all school staff to handle asthma related events in children  
Supporting Evidence Surveillance Evaluation Report  
Plan of Action to Achieve Change Monitor Change 
Change Needed Activities to 
implement 
Change 
Person  
Responsible 
Resources 
Required 
Due by Indicators that change 
is implemented 
Data sources Indicators to monitor 
success of change 
Make more efforts to get data and 
surveillance products into the hands 
of parents and community leaders 
Share data 
products with 
partners  
Explore social 
media options  
Asthma Contractor 
Asthma Evaluator  
School Nurses 
Schools PTA 
Partnerships/Workgr
oups  
Staff time 3/30/18 Number of products 
distributed to partners 
Number of outlets used 
to distribute products  
Number of partners 
distributing products 
Emails  
Meetings with 
partners 
Social Media 
sites/websites  
Number of products 
distributed to partners 
Number of outlets used to 
distribute products  
Number of partners 
distributing products 
Produce multiple surveillance 
documents for different audiences 
 
Development of 
factsheets, data 
summaries and 
infografics  
Specific to:  
Childcare centers 
Parents/Families 
Providers 
School Nurses 
CMOs/HCOs 
Youth   
Topics:  
General Asthma 
Devices and 
Medications 
Albuterol 
Stocking 
Asthma Contractor  
Asthma Evaluator 
Matrix Team  
Communications  
Partners  
Staff time  3/30/18 Number of documents 
produced for each topic 
and audience.   
Evaluation 
Convention data 
Surveillance Data  
Number of documents 
produced for each topic and 
audience 
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School Policies 
Action Plans  
Update surveillance data on a clear 
and consistent timeline 
Alternate data 
collection  
Chronic Disease 
Epidemiology 
OHIP 
Epidemiology 
leadership 
Chronic disease 
leadership 
Asthma evaluator 
 
 
Staff time  
IT support 
 
3/30/18 Schedule of when new 
data will be made 
available created.  
MOU’s with 
Epidemiology 
department  
 
MOU  Schedule of when new data 
will be made available 
created.  
MOU’s with Epidemiology 
department  
 
Train all school staff to handle 
asthma related events in children  
Meetings with 
school staff and 
school nurses. 
Provide webinar 
trainings  
  
GACP MATRIX 
team  
School nurses  
Staff time  
School 
Support  
3/30/18 Webinar made available  
  
Webinar 
Funded districts 
 
Number of school staff 
trained through webinar 
series 
   
33 
 
 
Appendices 
   
34 
Appendix A 
 
 
 
 
Interview Questions  
 
1. Do you use Asthma Surveillance Data?  
2. What is keeping you from using the data? 
3. Would you be interested in using the data? 
4. We have a variety of asthma surveillance products which products are you familiar with? 
Which products do you use?  
5.  How were you referred to the asthma surveillance data?  How do you access our asthma 
surveillance information? 
6. Do you find that you need specific technical skills to access the information on OASIS? 
Is it easy for you to access asthma surveillance information through the various sources 
we have available? 
7. Are you finding issues using the data with the software that you use? 
8.  Are there ways that you receive asthma surveillance products without access to a 
computer or Internet?  
9. Do you distribute/share any of our asthma surveillance products to others? Or point 
others to our website to access resources.  
10.  How do you use information from the asthma surveillance products?  
11.  Are you involved in policy and program planning or other efforts? how have  you used 
the asthma surveillance products to support these efforts? 
12.  Of the products used in policy and program planning where did you pull the data from?   
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Appendix B 
 
Focus Group Questions  
 
1. How do you access asthma control data? 
2. What are your thoughts about the surveillance products produced?  
 how can we improve?  
3. Are there other reports of information that would be helpful besides factsheets, info graphics 
and burden reports?  
4. What kind of places have you seen asthma surveillance products made available to the public?  
5. Do you use other sources of asthma surveillance data beyond that produced by the Georgia 
Asthma Control Program? 
If so, what are those sources? 
6. Are there specific policies and programs that were implemented as a result of the surveillance 
products?  
 If so, how successful was the policy or program and achieving its objective?  
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Appendix C 
 
Content Analysis Documents 
Surveillance Document  Readability Grade 
Info Graphic: Asthma Among Children, for 
Parents and Caregivers 
Below 12th  
Info Graphic: Asthma Among Children, for 
Healthcare Providers 
-  
2010 Asthma and Secondhand Smoke - 
2010 Data Summary - 
2010 Program and Data Summary - 
2012 Asthma Surveillance Report Below 12th  
2013 Adult Asthma Fact Sheet - 
2013 Child Asthma Fact Sheet - 
2014 Asthma Prevalence Report - 
2015 Data Summary: Asthma in Children Below 12th  
2015 Data Summary: Adult Asthma Below 12th  
2015 Asthma Burden Report Below 12th  
2016 Child Data Summary Below 12th  
2016 Adult Data Summary Below 12th  
( - ) indicates that the readability was unable to be determined  
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Appendix D 
 
Planned Standards and Evaluation Results  
Evaluation Question Standard Results 
N (%) 
To what extent is asthma data 
accessible to stakeholders in 
the most appropriate format to 
inform program planning, 
implementation, and 
evaluation? 
 
60% of stakeholders reporting 
satisfaction with accessibility 
 
12 (100%) 
Who is accessing asthma 
surveillance data? 
 
At least 2 identified parties Mercer University 
Asthma Center 
Children’s Healthcare of 
Atlanta 
National Association of 
School Nurses 
Georgia Association of School 
Nurses 
Georgia Asthma Coalition 
CDC 
Public Health Board 
Pediatric Healthcare 
Improvement Coalition  
Interns at EPA 
Asthma Task Force 
Fulton County School District 
Not One More Life  
The American Lung 
Association 
Are there gaps in the data that 
is presently available? 
 
At least 2 new types of 
information identified 
 
Children who have parents 
that smoke 
Associations between asthma, 
insurance coverage and access 
to healthcare  
Daily rates of ER visits  
Aggregate number of children 
with asthma within each 
school district 
Asthma mortality and asthma 
related deaths  
What technical assistance on 
data access and interpretation? 
At least 1 specific technical 
skill and/or software necessary 
to access the information 
identified 
 
Understanding how to filter 
results when using OASIS  
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To what extent do users rate 
asthma surveillance products 
as accessible, user friendly, 
and useful? 
 
60% of stakeholders reporting 
that they use asthma 
surveillance products in their 
daily lives 
 
9 (75%) 
60% of surveillance 
documents require a reading 
level below the 12th grade 
 
100% (14)* 
50% (7/14)**  
To what extent is asthma 
surveillance data used to 
inform policy and program 
planning efforts across the 
state? 
 
At least 1 policy and/or 
program implemented as a 
result of asthma surveillance 
products 
 
Not One More Life 
New Ronald McDonald 
/CHOA asthma van  
* Percent of documents that were below the 12th grade reading level, excluding those that were unable to be 
determined  
** Percent of documents that were below the 12th grade reading level, including those that were unable to 
be determined 
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Appendix E 
Additional Positive Comments  
The Asthma data is very useful for press releases  
Asthma data helps healthcare workers understand the population  
Provides good information for grant writing and educational purposes 
BRFS is a good well-known dataset with a strong methodology and a strong representative 
sample that is large enough to draw conclusions.  
Overview session of OASIS service was very helpful  
Data presents opportunity to focus on asthma and helps get resources and services to children 
with asthma 
Surveillance documents are easy to read, info graphic are really good and the Fact Sheets are 
really useful  
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Appendix F 
Additional Negative Comments 
OASIS was difficult and time consuming to learn at first. 
Data surveillance products not understandable for all populations.  
Understanding how to filter results in OASIS was difficult at first, as well as figuring out what is 
available in the dataset.  
Communication between people who completed the data analysis in previous years is lacking, 
making it impossible to obtain statistical code that were used in previous analyses. This made it 
difficult to insure that the analysis methods were the same the following year.  
It takes a long time to get new datasets  
Data not always presented in a way that is needed, for example daily rates of ER visits.  
Data not very accessible to school nurses  
Some surveillance documents are too lengthy  
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Appendix G 
 
Recommendations from Stakeholders  
Produce more raw numbers instead of percentages. 
Use social media and press releases to get information out to the public.  
Have data analysis meet with DPH staff to brainstorm on what we should report and disseminate. 
Sit down with Dr. O'Connor on how to make reports better (visually, data present, dissemination) 
using social media more effectively than posting to website. 
Training in the OASIS service. 
Have DPH meet with school nurses annually. 
Make data more accessible to school nurses. 
Produce asthma data specific to school districts. 
Have DPH staff attend GASN conferences. 
Collaborate with Step Up and Be Counted and other initiatives in order to share data. 
Present at the school nurse workshop presented by Gale Smith at Children Healthcare of Atlanta. 
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Appendix H 
Evaluation/Data Management 
 
 
Roles and Responsibilities of the Evaluation Team Members 
Individual Title or Role Responsibilities 
Lauren Potts  Evaluation Intern  Facilitate development of evaluation plan 
Identification/Development of data 
collection tools 
Data collection & analysis 
Communicate evaluation findings 
Oversight of evaluation activities 
Stephanie Hall  GACP Evaluator Advise on development of evaluation plan 
Review evaluation plan 
Review data collection tools 
Oversight of evaluation activities 
Kia Powell- Threats  Acting Director, Reporting 
& Evaluation Unit 
Advise on development of evaluation plan 
Review evaluation plan 
Review data collection tools 
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Appendix I 
Data Collection Management 
 
 
Evaluation 
Question 
Data Collection 
Method 
Activities 
Needed 
Person(s) 
Responsible 
Due Date 
1. To what extent is 
asthma data accessible 
to stakeholders in the 
most appropriate 
format to inform 
program planning, 
implementation, and 
evaluation? 
Interview Develop interview 
questions 
Schedule interviews 
Analyze responses 
Evaluation 
Intern 
March 2017 
Focus Group Develop focus 
group questions 
Schedule focus 
groups 
Analyze responses  
Evaluation 
Intern 
March 2017 
Content Analysis  Compile 
surveillance 
documents & 
written data 
requests 
Review & discuss 
documents 
Evaluation 
Intern 
February 
2017 
2. Who is accessing 
asthma surveillance 
data? 
Interview Develop interview 
questions 
Schedule interviews 
Analyze responses 
Evaluation 
Intern 
March 2017 
Content Analysis  Compile 
surveillance 
documents & 
written data 
requests 
Review & discuss 
documents 
Evaluation 
Intern 
February 
2017 
3. Are there gaps in the 
data that is presently 
available? 
Focus Group  Develop focus 
group questions 
Schedule focus 
groups 
Analyze responses 
Evaluation 
Intern 
March 2017 
Content Analysis  Compile 
surveillance 
documents & 
written data 
requests 
Review & discuss 
documents 
Evaluation 
Intern 
February 
2017 
4. What technical 
assistance on data 
access and 
interpretation? 
Interview Develop interview 
questions 
Schedule interviews 
Analyze responses 
Evaluation 
Intern 
March 2017 
Content Analysis  Compile 
surveillance 
documents & 
written data 
requests 
Review & discuss 
documents 
Evaluation 
Intern 
February 
2017 
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5. To what extent do 
users rate asthma 
surveillance products as 
accessible, user 
friendly, and useful? 
Interview Develop interview 
questions 
Schedule interviews 
Analyze responses 
Evaluation 
Intern 
March 2017 
Focus Group Develop focus 
group questions 
Schedule focus 
groups 
Analyze responses 
Evaluation 
Intern 
March 2017 
Content Analysis  Compile 
surveillance 
documents & 
written data 
requests 
Review & discuss 
documents 
Evaluation 
Intern 
February 
2017 
6. To what extent is 
asthma surveillance 
data used to inform 
policy and program 
planning efforts across 
the state? 
Interview  Develop interview 
questions 
Schedule interviews 
Analyze responses 
Evaluation 
Intern 
March 2017 
Focus Group  Develop focus 
group questions 
Schedule focus 
groups 
Analyze responses 
Evaluation 
Intern 
March 2017 
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Appendix J 
Data Analysis Management and Interpretation 
 
Data Analysis Plan 
Analysis to Be Performed Data to Be Analyzed  
Person(s) 
Responsible 
Due Date 
Descriptive Summary  Interview and focus 
group data 
Evaluation Intern  March 2017 
Content Analysis  Burden reports, Asthma 
Data summaries, 
Surveillance Data 
Request log,  
Surveillance data sources 
(e.g. BRFSS, Asthma 
Callback Survey) 
Evaluation Intern  February 2017 
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Appendix K 
Communicating and Reporting Management 
 
 
Communication and Reporting Plan 
 Audience 1: Surveillance Evaluation Team 
Applicable? (√)
√√ 
Purpose of Communication 
Possible 
Formats 
Possible 
Messenger Timing/Dates Notes 
Yes Include in decision making about 
evaluation design/activities 
Meetings  
Emails 
Evaluation Intern Monthly   
Yes  Inform about specific upcoming 
evaluation activities 
Meetings  
Emails 
Evaluation Intern As Needed   
Yes Keep informed about progress of the 
evaluation 
Meetings  
Emails 
Evaluation Intern As needed   
Yes Present initial/interim findings Email 
Presentation 
Evaluation Intern March 2017  
Yes  Present complete/final findings Email 
Presentation 
Evaluation Intern April 2017  
Yes  Document the evaluation and its 
findings 
Summary 
Report  
Evaluation Intern April 2017  
Yes  Document implementation of 
actions taken because of the 
evaluation  
Action Plan  Evaluation Intern April 2017   
Adapted from Russ-Eft and Preskill, 2001, pp. 354–357. 
 
 Audience 2: Georgia Asthma Advisory Board  
Applicable? (√)
√√ 
Purpose of Communication 
Possible 
Formats 
Possible 
Messenger Timing/Dates Notes 
Y Include in decision making about 
evaluation design/activities 
Email 
Presentation  
Evaluation Intern As Needed  
Yes  Inform about specific upcoming 
evaluation activities 
Email Evaluation Intern One month prior to 
activity  
 
Yes Keep informed about progress of the 
evaluation 
Email 
Meeting 
Presentation 
Evaluation Intern Quarterly   
Yes Present initial/interim findings Meeting 
Presentation 
Evaluation Intern March 2017  
Yes  Present complete/final findings Meeting 
Presentation 
Evaluation Intern April 2017  
Yes  Document the evaluation and its 
findings 
Email  
Website  
Evaluation Intern April 2017  
Yes  Document implementation of 
actions taken because of the 
evaluation  
Action Plan  Evaluation Intern April 2017   
Adapted from Russ-Eft and Preskill, 2001, pp. 354–357. 
 
 Audience 3: CDC 
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Applicable? (√)
√√ 
Purpose of Communication 
Possible 
Formats 
Possible 
Messenger Timing/Dates Notes 
Yes Include in decision making about 
evaluation design/activities 
Email  
Conference 
Call 
Evaluation Intern As needed  
Yes Inform about specific upcoming 
evaluation activities 
Email 
Conference 
call 
Evaluator Monthly  
Yes Keep informed about progress of the 
evaluation 
Email 
Conference 
Call 
Evaluator 
Evaluation Intern 
Monthly   
Yes Present initial/interim findings Email 
 
Evaluation Intern March 2017  
Yes  Present complete/final findings Email 
 
Evaluation Intern April 2017  
Yes  Document the evaluation and its 
findings 
Summary 
Report  
Conference 
Call 
Evaluation Intern April 2017  
Yes  Document implementation of 
actions taken because of the 
evaluation  
Action Plan  Evaluation Intern April 2017   
Adapted from Russ-Eft and Preskill, 2001, pp. 354–357. 
 
 
 
 Audience 4: General Public  
Applicable? (√)
√√ 
Purpose of Communication 
Possible 
Formats 
Possible 
Messenger Timing/Dates Notes 
No Include in decision making about 
evaluation design/activities 
    
No Inform about specific upcoming 
evaluation activities 
    
No Keep informed about progress of the 
evaluation 
    
No Present initial/interim findings     
No Present complete/final findings     
Yes  Document the evaluation and its 
findings 
Website  Evaluation Intern April 2017  
Yes  Document implementation of 
actions taken because of the 
evaluation  
Action Plan  Evaluation Intern April 2017   
Adapted from Russ-Eft and Preskill, 2001, pp. 354–357. 
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Appendix L 
Timeline 
  
 Task 
January 2017 – 
February 2017  
March 2017 – 
April 2017 
Planning and administrative tasks February 15th, 2017  
Pilot testing February 15th, 2017  
Formal data collection & analysis   March 30th, 2017 
Report summary &dissemination   March 30th, 2017 
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